GB0215775D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number: GB0215775D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical compounds; pharmaceutical; compounds
Prior art date: 2002-07-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0215775A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astex Technology Ltd

Original Assignee

Astex Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-06

Filing date

2002-07-06

Publication date

2002-08-14

2002-07-06 Application filed by Astex Technology Ltd filed Critical Astex Technology Ltd

2002-07-06 Priority to GB0215775A priority Critical patent/GB0215775D0/en

2002-08-14 Publication of GB0215775D0 publication Critical patent/GB0215775D0/en

2003-07-04 Priority to PCT/GB2003/002905 priority patent/WO2004004730A2/en

2003-07-04 Priority to AU2003242860A priority patent/AU2003242860A1/en

Status Ceased legal-status Critical Current

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GB0215775A GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds
PCT/GB2003/002905 WO2004004730A2 (en)	2002-07-06	2003-07-04	2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders
AU2003242860A AU2003242860A1 (en)	2002-07-06	2003-07-04	2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0215775A GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds

Publications (1)

Publication Number	Publication Date
GB0215775D0 true GB0215775D0 (en)	2002-08-14

Family

ID=9940040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0215775A Ceased GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds

Country Status (3)

Country	Link
AU (1)	AU2003242860A1 (en)
GB (1)	GB0215775D0 (en)
WO (1)	WO2004004730A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2398781B (en)	2002-05-23	2005-02-02	Cytopia Pty Ltd	Kinase inhibitors
US20080194574A1 (en) *	2003-12-16	2008-08-14	Axxima Pharmaceuticals Ag	Pyrazine Derivatives As Effective Compounds Against Infectious Diseases
WO2005097765A1 (en) *	2004-03-31	2005-10-20	Exelixis, Inc.	Anaplastic lymphoma kinase modulators and methods of use
WO2005121126A1 (en)	2004-04-13	2005-12-22	Icagen, Inc.	Polycyclic pyrazines as potassium ion channel modulators
WO2006044826A2 (en) *	2004-10-20	2006-04-27	Compass Pharmaceuticals Llc	Thiophens and their use as anti-tumor agents
GB0719644D0 (en) *	2007-10-05	2007-11-14	Cancer Rec Tech Ltd	Therapeutic compounds and their use
DE102008022788A1 (en) *	2008-05-08	2009-11-12	Süd-Chemie AG	New 2,6-pyrazine bridged transition metal carbene complex useful as a catalyst for oxidation of hydrocarbons
CN102448951B (en) *	2009-04-06	2017-05-10	安吉奥斯医药品有限公司	Therapeutic compositions and related methods of use
DK2427441T3 (en)	2009-05-04	2017-03-20	Agios Pharmaceuticals Inc	PKM2 Activators for use in the treatment of cancer
CA2766873C (en)	2009-06-29	2018-08-21	Agios Pharmaceuticals, Inc.	Therapeutic compositions and related methods of use
SMT201700309T1 (en)	2009-06-29	2017-07-18	Agios Pharmaceuticals Inc	Quinoline-8-sulfonamide derivatives having an anticancer activity
CA2821975A1 (en)	2010-12-17	2012-06-21	Shunqi Yan	N-(4-(azetidine-1-carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 pkm2 modulators
US9328077B2 (en)	2010-12-21	2016-05-03	Agios Pharmaceuticals, Inc	Bicyclic PKM2 activators
TWI549947B (en)	2010-12-29	2016-09-21	阿吉歐斯製藥公司	Therapeutic compounds and compositions
WO2012151440A1 (en)	2011-05-03	2012-11-08	Agios Pharmaceuticals, Inc.	Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
KR101873543B1 (en)	2011-05-03	2018-07-02	아지오스 파마슈티컬스 아이엔씨.	Pyruvate kinase activators for use in therapy
HK1215250A1 (en)	2013-01-30	2016-08-19	Bayer Pharma Aktiengesellschaft	Amino-substituted isothiazoles
WO2014139144A1 (en)	2013-03-15	2014-09-18	Agios Pharmaceuticals, Inc.	Therapeutic compounds and compositions
CN105985322A (en) *	2015-03-03	2016-10-05	苏州翔实医药发展有限公司	Amino pyrazine compound and application thereof
MD3307271T2 (en)	2015-06-11	2024-01-31	Agios Pharmaceuticals Inc	Methods of using pyruvate kinase activators
CN112142716B (en) *	2020-10-29	2021-08-31	山东新时代药业有限公司	5-membered heteroaryl substituted pyrazine derivative and application thereof
AU2023334156A1 (en) *	2022-09-02	2025-02-27	Miralogx Llc	Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis, and other disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4868183A (en) *	1986-07-21	1989-09-19	Otsuka Pharmaceutical Factory, Inc.	N-pyrazinyl substituted P-aminophenols
GR900100380A (en) *	1989-05-20	1991-10-10	Fisons Plc	Method of preparation of anti-inflammatory derivatives of aminophenol.
WO1999062885A1 (en) *	1998-06-05	1999-12-09	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
SE9903894D0 (en) *	1999-10-28	1999-10-28	New Pharma Research Ab	Novel compounds
SE9904108D0 (en) *	1999-11-15	1999-11-15	New Pharma Research Ab	New compounds
DK1330452T3 (en) *	2000-09-20	2009-03-16	Ortho Mcneil Janssen Pharm	Pyrazine derivatives as modulators of tyrosine kinases
AU2002224266B2 (en) *	2000-11-20	2007-05-24	Biovitrum Ab	Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
EP1363702A4 (en) *	2001-01-30	2007-08-22	Cytopia Pty Ltd	Methods of inhibiting kinases
WO2003031406A2 (en) *	2001-10-12	2003-04-17	Irm Llc	Kinase inhibitor scaffolds and methods for their preparation
GB0124939D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds

2002
- 2002-07-06 GB GB0215775A patent/GB0215775D0/en not_active Ceased
2003
- 2003-07-04 AU AU2003242860A patent/AU2003242860A1/en not_active Abandoned
- 2003-07-04 WO PCT/GB2003/002905 patent/WO2004004730A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004004730A3 (en)	2004-04-29
WO2004004730A2 (en)	2004-01-15
AU2003242860A8 (en)	2004-01-23
AU2003242860A1 (en)	2004-01-23

Publication	Publication Date	Title
GB0218625D0 (en)	2002-09-18	Pharmaceutical compounds
EG27104A (en)	2015-06-09	Pharmaceutical compounds
GB0217225D0 (en)	2002-09-04	Medicinal compounds
GB0225540D0 (en)	2002-12-11	Medicinal compounds
GB0204719D0 (en)	2002-04-17	Medicinal compounds
GB0225535D0 (en)	2002-12-11	Medicinal compounds
GB0220730D0 (en)	2002-10-16	Medicinal compounds
GB0225030D0 (en)	2002-12-04	Medicinal compounds
GB0315657D0 (en)	2003-08-13	Pharmaceutical compounds
GB0215775D0 (en)	2002-08-14	Pharmaceutical compounds
GB0308511D0 (en)	2003-05-21	Pharmaceutical compounds
GB0317315D0 (en)	2003-08-27	Pharmaceutical compounds
GB0313766D0 (en)	2003-07-23	Pharmaceutical compounds
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
GB0301736D0 (en)	2003-02-26	Pharmaceutical compounds
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
GB0204392D0 (en)	2002-04-10	Pharmaceutical compound
GB0329617D0 (en)	2004-01-28	Pharmaceutical compounds
GB0310361D0 (en)	2003-06-11	Pharmaceutical compound
GB0208248D0 (en)	2002-05-22	Pharmaceutical compounds
GB0215939D0 (en)	2002-08-21	Pharmaceutical compounds
GB0215180D0 (en)	2002-08-07	Pharmaceutical compounds
GB0230153D0 (en)	2003-02-05	Pharmaceutical compounds
GB0204391D0 (en)	2002-04-10	Pharmaceutical compound
GB0212459D0 (en)	2002-07-10	Pharmaceutical compound

Legal Events

Date	Code	Title	Description
2003-10-01	AT	Applications terminated before publication under section 16(1)